Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset

[1]  J. Todd,et al.  Conditional linkage disequilibrium analysis of a complex disease superlocus, IDDM1 in the HLA region, reveals the presence of independent modifying gene effects influencing the type 1 diabetes risk encoded by the major HLA-DQB1, -DRB1 disease loci. , 2001, Human molecular genetics.

[2]  T. Ogihara,et al.  Analysis by the polymerase chain reaction of histocompatibility leucocyte antigen-DR9-linked susceptibility to insulin-dependent diabetes mellitus. , 1992, The Journal of clinical endocrinology and metabolism.

[3]  H. K. Lee,et al.  Fulminant type 1 diabetes in Korea: high prevalence among patients with adult-onset type 1 diabetes , 2007, Diabetologia.

[4]  H. Inoko,et al.  Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population. , 2000, Tissue antigens.

[5]  B. Charbonnel,et al.  Fulminant type 1 diabetes in Caucasians: A report of three cases. , 2008, Diabetes & metabolism.

[6]  T. Kobayashi,et al.  Immunogenetic and Clinical Characterization of Slowly Progressive IDDM , 1993, Diabetes Care.

[7]  A. Imagawa,et al.  High titres of IgA antibodies to enterovirus in fulminant type-1 diabetes , 2005, Diabetologia.

[8]  T. Ogihara,et al.  Asian-specific HLA haplotypes reveal heterogeneity of the contribution of HLA-DR and -DQ haplotypes to susceptibility to type 1 diabetes. , 2002, Diabetes.

[9]  S. Kashiwagi,et al.  Contribution of HLA class I and class II alleles to the regulation of antibody production to hepatitis B surface antigen in humans. , 1996, International immunology.

[10]  J. Todd,et al.  HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. , 1987, Nature.

[11]  H. Onuma,et al.  Differences in the contribution of HLA-DR and -DQ haplotypes to susceptibility to adult- and childhood-onset type 1 diabetes in Japanese patients. , 2004, Diabetes.

[12]  A. Imagawa,et al.  Pathogenesis of fulminant type 1 diabetes. , 2006, The review of diabetic studies : RDS.

[13]  Y. Iwamoto,et al.  Genetic analysis of HLA class II alleles and susceptibility to Type 1 (insulin-dependent) diabetes mellitus in Japanese subjects , 1992, Diabetologia.

[14]  Y. Matsuzawa,et al.  A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. , 2000, The New England journal of medicine.

[15]  A. Shimada,et al.  Encephalomyocarditis-virus-induced diabetes model resembles “fulminant” Type 1 diabetes in humans , 2004, Diabetologia.

[16]  A. Imagawa,et al.  Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners , 2007, Nature Clinical Practice Endocrinology &Metabolism.

[17]  Masako Furukawa,et al.  Single-nucleotide-polymorphism genotyping for whole-genome-amplified samples using automated fluorescence correlation spectroscopy. , 2004, Analytical biochemistry.

[18]  今川 彰久.  A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies , 2000 .

[19]  M. Rowley,et al.  Latent Autoimmune Diabetes Mellitus in Adults (LADA): the Role of Antibodies to Glutamic Acid Decarboxylase in Diagnosis and Prediction of Insulin Dependency , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[20]  T. Kobayashi,et al.  Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus , 2007, Diabetologia.